HUS2400006I1 - Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció - Google Patents

Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció

Info

Publication number: HUS2400006I1
Authority: HU; Hungary
Prior art keywords: combination containing; stable crystal; oxoquinoline compound; oxoquinoline; compound
Prior art date: 2004-05-20

Application number

HUS2400006C

Other languages

English (en)

Original Assignee

Japan Tobacco Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-20

Filing date

2024-03-20

Publication date

2024-04-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35079161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS2400006(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2024-03-20 Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc

2024-04-28 Publication of HUS2400006I1 publication Critical patent/HUS2400006I1/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)

HUS2400006C 2004-05-20 2024-03-20 Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció HUS2400006I1 (hu)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2004150979		2004-05-20
EP17186674.2A EP3281939B1 (en)	2004-05-20	2005-05-19	Combination comprising a stable crystal of a 4-oxoquinoline compound

Publications (1)

Publication Number	Publication Date
HUS2400006I1 true HUS2400006I1 (hu)	2024-04-28

Family

ID=35079161

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HUE17186674A HUE064615T2 (hu)	2004-05-20	2005-05-19	Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció
HUS2400006C HUS2400006I1 (hu)	2004-05-20	2024-03-20	Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
HUE17186674A HUE064615T2 (hu)	2004-05-20	2005-05-19	Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció

Country Status (33)

Country	Link
US (7)	US7635704B2 (hu)
EP (4)	EP2514746A1 (hu)
JP (1)	JP3754064B2 (hu)
KR (1)	KR20080064909A (hu)
CN (1)	CN1956961B (hu)
AR (2)	AR049280A1 (hu)
AU (1)	AU2005245296B2 (hu)
BE (1)	BE2024C511I2 (hu)
BR (1)	BRPI0510114B8 (hu)
CA (1)	CA2566922C (hu)
CY (4)	CY1113010T1 (hu)
DK (2)	DK1636190T3 (hu)
ES (2)	ES2960824T3 (hu)
FI (2)	FI3281939T3 (hu)
FR (1)	FR23C1040I1 (hu)
HR (2)	HRP20231588T3 (hu)
HU (2)	HUE064615T2 (hu)
IL (1)	IL179250A0 (hu)
LT (2)	LT3281939T (hu)
LU (1)	LUC00334I2 (hu)
MX (1)	MXPA06013405A (hu)
MY (1)	MY134672A (hu)
NO (8)	NO339223B1 (hu)
NZ (1)	NZ551839A (hu)
PE (2)	PE20120361A1 (hu)
PL (2)	PL3281939T3 (hu)
PT (2)	PT1636190E (hu)
RS (2)	RS64845B1 (hu)
RU (1)	RU2330845C1 (hu)
SI (2)	SI3281939T1 (hu)
TW (1)	TWI329015B (hu)
WO (1)	WO2005113508A1 (hu)
ZA (1)	ZA200610647B (hu)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6891227B2 (en)	2002-03-20	2005-05-10	International Business Machines Corporation	Self-aligned nanotube field effect transistor and method of fabricating same
DE60329318D1 (de) *	2002-11-20	2009-10-29	Japan Tobacco Inc	4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren
MY134672A (en) *	2004-05-20	2007-12-31	Japan Tobacco Inc	Stable crystal of 4-oxoquinoline compound
WO2007063869A1 (ja) *	2005-11-30	2007-06-07	Japan Tobacco Inc.	高純度キノロン化合物の製造方法
US20090233964A1 (en) *	2005-12-30	2009-09-17	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
AU2013203476C1 (en) *	2005-12-30	2016-11-17	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
SG170795A1 (en) *	2005-12-30	2011-05-30	Gilead Sciences Inc	Methods for improving the pharmacokinetics of hiv integrase inhibitors
US20090018162A1 (en) *	2006-02-01	2009-01-15	Yuji Matsuzaki	Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
WO2007092802A1 (en) *	2006-02-09	2007-08-16	Boehringer Ingelheim International Gmbh	Method for treating hiv infection through co-administration of tipranavir and gs 9137
CN101437801B (zh)	2006-03-06	2013-02-06	日本烟草产业株式会社	制备4-氧代喹啉化合物的方法
BRPI0708685B8 (pt) *	2006-03-06	2021-05-25	Japan Tobacco Inc	composto de 4-oxoquinolina, seu uso e método para produção dos mesmos
ME02258B (me)	2006-07-07	2015-12-31	Gilead Sciences Inc	Modulatori farmakokinetičkih svojstava terapeutika
TWI411602B (zh)	2006-09-12	2013-10-11	Gilead Sciences Inc	製造整合酶抑制劑的方法及彼所用的中間物
PL2487161T5 (pl) *	2007-02-23	2024-09-09	Gilead Sciences, Inc.	<div>Modulatory właściwości farmakokinetycznych środków terapeutycznych</div><div> </div>
NZ582089A (en) *	2007-06-29	2013-01-25	Gilead Sciences Inc	Antiviral Combination of elvitegravir, lopinavir and optionally ritonavir
TW200914011A (en) *	2007-06-29	2009-04-01	Gilead Sciences Inc	Therapeutic compositions and methods
AR068403A1 (es)	2007-09-11	2009-11-18	Gilead Sciences Inc	Proceso e intermediarios para la preparacion de inhibidores de integrasa
PL2296633T3 (pl)	2008-05-02	2016-03-31	Gilead Sciences Inc	Zastosowanie cząsteczek stałych nośników dla udoskonalenia przetwarzalności środka farmaceutycznego
AP3250A (en)	2009-02-06	2015-05-31	Gilead Sciences Inc	Tablets for combination therapy
WO2010137032A2 (en) *	2009-05-14	2010-12-02	Matrix Laboratories Ltd.	Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts
WO2011004389A2 (en) *	2009-06-18	2011-01-13	Matrix Laboratories Ltd	An improved process for the preparation of elvitegravir
CN102212032B (zh) *	2011-04-20	2013-07-31	复旦大学	一种5-羟基喹诺酮类衍生物及其制备方法和用途
BR112015000187A2 (pt)	2012-07-06	2017-06-27	Genentech Inc	benzamidas substituídas com n e métodos de uso das mesmas
AU2013296289B2 (en)	2012-08-03	2017-10-05	Gilead Sciences, Inc.	Process and intermediates for preparing integrase inhibitors
CN103819402B (zh) *	2012-11-17	2016-03-30	上海迪赛诺化学制药有限公司	埃替拉韦中间体及其制备方法和应用
CN103864682B (zh) *	2012-12-18	2016-12-28	上海迪赛诺化学制药有限公司	一种制备iii型埃替拉韦晶体的方法
PE20151499A1 (es)	2012-12-21	2015-10-29	Gilead Sciences Inc	Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico
EP3252058B1 (en)	2013-07-12	2021-01-20	Gilead Sciences, Inc.	Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections
NO2865735T3 (hu)	2013-07-12	2018-07-21
CN105315203A (zh) *	2014-06-06	2016-02-10	上海迪赛诺化学制药有限公司	一种v型埃替拉韦晶体及其制备方法
TW201613936A (en)	2014-06-20	2016-04-16	Gilead Sciences Inc	Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
NO2717902T3 (hu)	2014-06-20	2018-06-23
TWI744723B (zh)	2014-06-20	2021-11-01	美商基利科學股份有限公司	多環型胺甲醯基吡啶酮化合物之合成
TWI695003B (zh)	2014-12-23	2020-06-01	美商基利科學股份有限公司	多環胺甲醯基吡啶酮化合物及其醫藥用途
KR20190057158A (ko)	2015-04-02	2019-05-27	길리애드 사이언시즈, 인코포레이티드	폴리시클릭-카르바모일피리돈 화합물 및 그의 제약 용도
CN106008195B (zh) *	2016-05-19	2018-08-03	绍兴文理学院	一种2，4-二氟-5-碘苯甲酸的制备方法
EP3984536B1 (en) *	2020-10-19	2025-06-25	Centre national de la recherche scientifique	Inhibition of the hiv-1 replication by compounds directed against a new target of the viral cycle

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3472859A (en) *	1966-11-01	1969-10-14	Sterling Drug Inc	1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
JPS567162B1 (hu)	1970-09-14	1981-02-16
JPS4826772A (hu)	1971-08-11	1973-04-09
JPS6450979A (en)	1987-08-21	1989-02-27	Hitachi Shipbuilding Eng Co	Method for discriminating whistle sound
JPH0651229B2 (ja)	1989-07-31	1994-07-06	新日本製鐵株式会社	プラズマアーク溶接方法および装置
IL100555A (en) *	1991-02-07	2000-08-31	Hoechst Marion Roussel Inc	N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
JP2993316B2 (ja)	1992-05-27	1999-12-20	宇部興産株式会社	アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤
NO304832B1 (no) *	1992-05-27	1999-02-22	Ube Industries	Aminokinolonderivater samt middel mot HIV
JPH06199835A (ja)	1993-01-08	1994-07-19	Hokuriku Seiyaku Co Ltd	８−ジフルオロメトキシキノリン−３−カルボン酸誘導体
JPH06271568A (ja)	1993-03-22	1994-09-27	Hokuriku Seiyaku Co Ltd	７−フェニルピペラジニルキノリン−３−カルボン酸誘導体
JP2930539B2 (ja)	1994-07-18	1999-08-03	三共株式会社	トリフルオロメチルキノリンカルボン酸誘導体
HUT76643A (en) *	1994-07-18	1997-10-28	Sankyo Co	Trifluoromethylquinolinecarboxylic acid derivative, pharmaceutical compositions containing them and their use
JPH0826772A (ja)	1994-07-22	1996-01-30	Sony Corp	融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
ES2171260T3 (es)	1996-04-12	2002-09-01	Us Gov Health & Human Serv	Compuestos derivados de acridona utiles como agentes antineoplasicos y antirretroviricos.
FR2761687B1 (fr) *	1997-04-08	2000-09-15	Centre Nat Rech Scient	Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
JP3776203B2 (ja)	1997-05-13	2006-05-17	第一製薬株式会社	Ｉｃａｍ−１産生阻害剤
GB9721964D0 (en) *	1997-10-16	1997-12-17	Pfizer Ltd	Isoquinolines
US6399629B1 (en)	1998-06-01	2002-06-04	Microcide Pharmaceuticals, Inc.	Efflux pump inhibitors
SE9802549D0 (sv) *	1998-07-15	1998-07-15	Active Biotech Ab	Quinoline derivatives
US6248736B1 (en)	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
US6248739B1 (en) *	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	Quinolinecarboxamides as antiviral agents
PE20011349A1 (es) *	2000-06-16	2002-01-19	Upjohn Co	1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
US6559145B2 (en)	2000-07-12	2003-05-06	Pharmacia & Upjohn Company	Heterocycle carboxamides as antiviral agents
EP1326610B1 (en)	2000-10-12	2006-11-15	Merck & Co., Inc.	Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
WO2002036734A2 (en)	2000-10-12	2002-05-10	Merck & Co., Inc.	Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
IL157638A0 (en)	2001-03-01	2004-03-28	Shionogi & Co	Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
JP2002293745A (ja)	2001-03-29	2002-10-09	St Marianna Univ School Of Medicine	慢性関節リウマチ治療剤
US20030138483A1 (en) *	2001-05-25	2003-07-24	Sergio Petriconi	Soft elastic capsules and compositions thereof
US6627646B2 (en) *	2001-07-17	2003-09-30	Sepracor Inc.	Norastemizole polymorphs
FR2827600A1 (fr)	2001-07-20	2003-01-24	Lipha	Derives acides de quinolone et leurs applications en therapeutique
RU2206564C1 (ru) *	2002-03-07	2003-06-20	Общество с ограниченной ответственностью "Поливит"	Способ получения этилового эфира 6-фтор-7-хлор-1,4-дигидро-4-оксо-3-хинолинкарбоновой кислоты
JP4035765B2 (ja)	2002-10-31	2008-01-23	横河電機株式会社	フーリエ変換型赤外線分光計
JP3567162B1 (ja)	2002-11-20	2004-09-22	日本たばこ産業株式会社	４−オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用
DE60329318D1 (de) *	2002-11-20	2009-10-29	Japan Tobacco Inc	4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren
MY134672A (en) *	2004-05-20	2007-12-31	Japan Tobacco Inc	Stable crystal of 4-oxoquinoline compound
WO2005113509A1 (en) *	2004-05-20	2005-12-01	Japan Tobacco Inc.	Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
EP3287130A1 (en) *	2004-05-21	2018-02-28	Japan Tobacco Inc.	Combinations comprising a 4-isoquinolone derivative and protease inhibitors

2005
- 2005-05-18 MY MYPI20052258A patent/MY134672A/en unknown
- 2005-05-19 DK DK05726243.8T patent/DK1636190T3/da active
- 2005-05-19 RS RS20231092A patent/RS64845B1/sr unknown
- 2005-05-19 PL PL17186674.2T patent/PL3281939T3/pl unknown
- 2005-05-19 EP EP12173572A patent/EP2514746A1/en not_active Withdrawn
- 2005-05-19 RU RU2006145302/04A patent/RU2330845C1/ru active
- 2005-05-19 AR ARP050102058A patent/AR049280A1/es not_active Application Discontinuation
- 2005-05-19 BR BRPI0510114A patent/BRPI0510114B8/pt active IP Right Grant
- 2005-05-19 PL PL05726243T patent/PL1636190T3/pl unknown
- 2005-05-19 KR KR1020087014768A patent/KR20080064909A/ko not_active Withdrawn
- 2005-05-19 LT LTEP17186674.2T patent/LT3281939T/lt unknown
- 2005-05-19 EP EP05726243A patent/EP1636190B1/en not_active Expired - Lifetime
- 2005-05-19 ZA ZA200610647A patent/ZA200610647B/en unknown
- 2005-05-19 HR HRP20231588TT patent/HRP20231588T3/hr unknown
- 2005-05-19 TW TW094116234A patent/TWI329015B/zh not_active IP Right Cessation
- 2005-05-19 RS RS20120306A patent/RS52375B/sr unknown
- 2005-05-19 WO PCT/JP2005/009604 patent/WO2005113508A1/en not_active Ceased
- 2005-05-19 NZ NZ551839A patent/NZ551839A/en not_active IP Right Cessation
- 2005-05-19 EP EP23203885.1A patent/EP4299563A3/en active Pending
- 2005-05-19 AU AU2005245296A patent/AU2005245296B2/en active Active
- 2005-05-19 SI SI200532315T patent/SI3281939T1/sl unknown
- 2005-05-19 CN CN2005800161426A patent/CN1956961B/zh not_active Expired - Lifetime
- 2005-05-19 HU HUE17186674A patent/HUE064615T2/hu unknown
- 2005-05-19 CA CA2566922A patent/CA2566922C/en not_active Expired - Lifetime
- 2005-05-19 DK DK17186674.2T patent/DK3281939T3/da active
- 2005-05-19 JP JP2005147219A patent/JP3754064B2/ja not_active Expired - Lifetime
- 2005-05-19 EP EP17186674.2A patent/EP3281939B1/en not_active Expired - Lifetime
- 2005-05-19 ES ES17186674T patent/ES2960824T3/es not_active Expired - Lifetime
- 2005-05-19 ES ES05726243T patent/ES2388441T3/es not_active Expired - Lifetime
- 2005-05-19 PT PT05726243T patent/PT1636190E/pt unknown
- 2005-05-19 PT PT171866742T patent/PT3281939T/pt unknown
- 2005-05-19 MX MXPA06013405A patent/MXPA06013405A/es active IP Right Grant
- 2005-05-19 FI FIEP17186674.2T patent/FI3281939T3/fi active
- 2005-05-19 HR HRP20120681TT patent/HRP20120681T1/hr unknown
- 2005-05-19 SI SI200531572T patent/SI1636190T1/sl unknown
- 2005-05-20 PE PE2011002129A patent/PE20120361A1/es active IP Right Grant
- 2005-05-20 US US11/133,471 patent/US7635704B2/en active Active
- 2005-05-20 PE PE2005000561A patent/PE20060358A1/es active IP Right Grant
2006
- 2006-11-14 IL IL179250A patent/IL179250A0/en active IP Right Grant
- 2006-12-14 NO NO20065790A patent/NO339223B1/no unknown
2009
- 2009-08-10 US US12/538,694 patent/US8981103B2/en active Active
2012
- 2012-07-11 CY CY20121100621T patent/CY1113010T1/el unknown
2014
- 2014-04-25 AR ARP140101722A patent/AR096100A2/es active IP Right Grant
2015
- 2015-01-09 US US14/593,946 patent/US20150361044A1/en not_active Abandoned
2016
- 2016-08-12 NO NO20161297A patent/NO20161297A1/no not_active Application Discontinuation
2017
- 2017-03-01 US US15/447,007 patent/US20180029989A1/en not_active Abandoned
2018
- 2018-07-20 US US16/041,458 patent/US20190185433A1/en not_active Abandoned
2019
- 2019-01-15 NO NO20190051A patent/NO20190051A1/no not_active Application Discontinuation
2020
- 2020-08-04 NO NO20200873A patent/NO20200873A1/no not_active Application Discontinuation
2021
- 2021-08-24 US US17/445,817 patent/US20220235009A1/en not_active Abandoned
2022
- 2022-06-17 NO NO20220690A patent/NO20220690A1/no not_active Application Discontinuation
2023
- 2023-08-25 NO NO20230913A patent/NO347902B1/no unknown
- 2023-09-28 CY CY2015009C patent/CY2015009I2/el unknown
- 2023-11-02 FR FR23C1040C patent/FR23C1040I1/fr active Active
- 2023-12-05 CY CY20231100714T patent/CY1126560T1/el unknown
2024
- 2024-03-14 LU LU00334C patent/LUC00334I2/fr unknown
- 2024-03-15 BE BE2024C511C patent/BE2024C511I2/nl unknown
- 2024-03-19 CY CY2024008C patent/CY2024008I2/el unknown
- 2024-03-20 HU HUS2400006C patent/HUS2400006I1/hu unknown
- 2024-03-20 FI FIC20240008C patent/FIC20240008I1/fi unknown
- 2024-03-26 LT LTPA2024001C patent/LTC3281939I2/lt unknown
- 2024-04-12 US US18/634,451 patent/US20250091995A1/en active Pending
- 2024-04-22 NO NO20240384A patent/NO20240384A1/no unknown
- 2024-07-15 NO NO2024034C patent/NO2024034I1/no unknown

Also Published As

Publication number	Publication date
BRPI0510114B1 (pt)	2020-09-15
PE20120361A1 (es)	2012-05-03
RS64845B1 (sr)	2023-12-29
FI3281939T3 (fi)	2023-10-23
HRP20231588T3 (hr)	2024-03-15
JP2006001927A (ja)	2006-01-05
LT3281939T (lt)	2023-11-27
US20150361044A1 (en)	2015-12-17
SI3281939T1 (sl)	2024-02-29
CY1113010T1 (el)	2016-04-13
AU2005245296A1 (en)	2005-12-01
LUC00334I2 (hu)	2024-07-01
NO20161297A1 (no)	2007-02-07
US20250091995A1 (en)	2025-03-20
US20060030710A1 (en)	2006-02-09
TW200600097A (en)	2006-01-01
MY134672A (en)	2007-12-31
LTC3281939I2 (hu)	2025-04-25
IL179250A0 (en)	2007-03-08
RU2330845C1 (ru)	2008-08-10
BE2024C511I2 (hu)	2024-10-08
PL1636190T3 (pl)	2012-10-31
EP2514746A1 (en)	2012-10-24
US20190185433A1 (en)	2019-06-20
SI1636190T1 (sl)	2012-09-28
US20100204271A1 (en)	2010-08-12
CY2015009I1 (el)	2024-09-20
FIC20240008I1 (fi)	2024-03-20
CN1956961B (zh)	2010-05-26
NO347902B1 (no)	2024-05-06
ZA200610647B (en)	2008-06-25
HK1083341A1 (en)	2006-06-30
MXPA06013405A (es)	2007-03-01
EP1636190B1 (en)	2012-06-27
NO339223B1 (no)	2016-11-21
US20220235009A1 (en)	2022-07-28
NO20200873A1 (no)	2007-02-07
CA2566922A1 (en)	2005-12-01
AR096100A2 (es)	2015-12-09
DK3281939T3 (da)	2024-01-22
CY2015009I2 (el)	2024-09-20
DK1636190T3 (da)	2012-09-24
JP3754064B2 (ja)	2006-03-08
NO20065790L (no)	2007-02-07
LTPA2024001I1 (hu)	2024-04-10
EP4299563A2 (en)	2024-01-03
PT1636190E (pt)	2012-08-20
PE20060358A1 (es)	2006-05-12
KR20080064909A (ko)	2008-07-09
HRP20120681T1 (hr)	2012-09-30
CN1956961A (zh)	2007-05-02
PL3281939T3 (pl)	2024-03-18
CA2566922C (en)	2011-01-11
AR049280A1 (es)	2006-07-12
HUE064615T2 (hu)	2024-04-28
FR23C1040I1 (fr)	2023-12-29
US7635704B2 (en)	2009-12-22
US20180029989A1 (en)	2018-02-01
NO2024034I1 (no)	2024-07-15
EP3281939B1 (en)	2023-10-18
NO20230913A1 (no)	2007-02-07
NO20190051A1 (no)	2007-02-07
AU2005245296B2 (en)	2010-08-12
NZ551839A (en)	2009-11-27
EP3281939A1 (en)	2018-02-14
RS52375B (sr)	2012-12-31
NO20220690A1 (no)	2007-02-07
PT3281939T (pt)	2023-11-22
WO2005113508A1 (en)	2005-12-01
EP1636190A1 (en)	2006-03-22
TWI329015B (en)	2010-08-21
ES2960824T3 (es)	2024-03-06
CY2024008I1 (el)	2024-09-20
NO20240384A1 (no)	2007-02-07
CY1126560T1 (el)	2024-09-20
BRPI0510114A (pt)	2007-09-25
US8981103B2 (en)	2015-03-17
BRPI0510114B8 (pt)	2021-05-25
CY2024008I2 (el)	2024-09-20
EP4299563A3 (en)	2024-02-28
ES2388441T3 (es)	2012-10-15

Publication	Publication Date	Title
HUS2400006I1 (hu)	2024-04-28	Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció
HUS2200020I1 (hu)	2022-06-28	Aktív vegyületeket tartalmazó fungicid kombinációk
DK2377869T3 (da)	2014-04-14	Syntese af Bortezomib
DK1778618T3 (da)	2014-03-10	Syntese af triethylentetraminer
BRPI0719351A2 (pt)	2014-01-07	Preparação adesiva estabilizada contendo donezepil
DE602004018429D1 (de)	2009-01-29	Multifunktions-armbanduhr
DK1487832T3 (da)	2007-11-05	Krystallinsk mikronisat af tiotropiumbromid
DK1874766T3 (da)	2010-12-06	Krystallinsk form af en quinolinon-carboxamid-forbindelse
ATE404546T1 (de)	2008-08-15	Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
IS8470A (is)	2006-05-16	Notkun lífrænna efnasambanda
IL182513A0 (en)	2007-09-20	Self-adhesive film for teeth
DK1705998T3 (da)	2014-08-25	Anvendelse af en carboxypeptidase
DE602004026790D1 (de)	2010-06-02	Stabilisierte propylbromidzusammensetzungen
DK1656358T3 (da)	2011-05-30	Stabil polymorf af bifeprunox-mesilat
NO20055097D0 (no)	2005-11-01	Krystallinske N-formyl-hydroksylaminforbindelser
IS7963A (is)	2005-07-28	Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa
DK1730109T3 (da)	2008-09-29	Syntese af pyrrol-2-carbonitriler
NO20044364L (no)	2004-12-09	Hydroksykarbamimidoyl-2-hydroksy-benzensulfonamidderivat-krystaller
SE0402103D0 (sv)	2004-08-30	Novel compounds
ATE384719T1 (de)	2008-02-15	Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
DE60221671D1 (de)	2007-09-20	Negativtypflüssigkristalle enthaltend Dotierstoffe
SE0400254D0 (sv)	2004-02-06	New compounds
UA9248S (uk)	2004-08-16	Календар історичних подій
SE0402069D0 (sv)	2004-08-24	Novel compounds
SE0403054D0 (sv)	2004-12-15	Novel compounds